Television is now the most widely used medium for direct-to-consumer pharmaceutical advertising, according to the latest study conducted by Market Measures Interactive, Livingston, NJ. In 2000, TV accounted for $949.5 million, 62% of all DTC ad dollars, up from the 57% of DTC budgets directed to TV in 1999. The rise in TV spending contrasts with a noticeable decline in DTC dollars directed to print media, including magazines and newspapers. As of September 2000, print media were attracting only 36% of DTC dollars - a drop from the 42% spent on DTC print ads in 1999.
Television is now the most widely used medium for direct-to-consumer pharmaceutical advertising, according to the latest study conducted by Market Measures Interactive, Livingston, NJ. In 2000, TV accounted for $949.5 million, 62% of all DTC ad dollars, up from the 57% of DTC budgets directed to TV in 1999. The rise in TV spending contrasts with a noticeable decline in DTC dollars directed to print media, including magazines and newspapers. As of September 2000, print media were attracting only 36% of DTC dollars - a drop from the 42% spent on DTC print ads in 1999.
As TV brings in more DTC dollars, it delivers greater awareness. According to the study, 61% of DTC awareness among consumers is attributed to television exposure (up from 19% in 1997), while only 38% comes from magazine exposure.
The percentage of consumers who contacted their doctors after seeing a DTC ad rose slightly from 20% in 1999 to 21% in September of 2000. The conditions contributing most to the increase in contact rates include vaginal yeast infection, cancer, chronic bronchitis and Alzheimer's disease.
Ads that contain new information are most likely to boost doctor contact rates, the study revealed. Consumers who perceive that an ad includes new information are more than twice as likely to contact their physicians as those who do not think an ad provides any new facts.
Even more significant than the rise in contact rates is the increase in the percentage of responding consumers who asked their physicians to write a prescription for the advertised product. The percentage of consumers making brand-specific requests to their doctors went up from 46% at the end of 1999 to 50% in September of 2000. Of those who made a request, 70% received a prescription for the brand they wanted - slightly down from the 1999 year-end figure of 73%.
"Proactive consumers can be a pharmaceutical company's strongest ally in the doctor's office," according to Peter Johnsen, MMI's vice president of DTC services. "If patients ask for a product, they will most likely receive it." PR
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.